Monthly Cost Breakdown: Wegovy vs Mounjaro Pricing
Understanding What 1mg Wegovy Means Compared to Mounjaro Monthly Cost Structure
When patients ask "what is 1mg Wegovy in Mounjaro", they're comparing two fundamentally different dosing approaches for weight management. Wegovy 1mg represents weeks 9-12 of your treatment journey, costing £99.99 per month, while Mounjaro uses a completely separate tirzepatide-based system with different dose strengths. Wegovy follows a structured 16-week escalation from 0.25mg to the maintenance dose of 2.4mg, with each monthly phase clearly defined. Mounjaro, as a dual GIP and GLP-1 receptor agonist, uses its own escalation schedule with different milligram strengths that don't directly correspond to Wegovy's system.
The monthly cost clarity becomes important when budgeting for your weight management journey, as both treatments require long-term commitment alongside a reduced-calorie diet and increased physical activity. Understanding what 1mg Wegovy represents in your overall treatment timeline helps you plan the financial commitment, knowing you'll progress to 1.7mg (£139.99) and eventually 2.4mg maintenance (£209.99 monthly). This transparency in monthly costs allows you to budget effectively for your prescription-only medicine, whether choosing Wegovy's GLP-1 approach or Mounjaro's dual-hormone mechanism.
Wegovy 1mg vs Mounjaro Pricing: Complete Monthly Cost Analysis
At EverydayMeds, Wegovy 1mg costs £99.99 per pen (after FIRST40 discount for new customers, DOSE25 for returning patients), representing excellent value during your dose escalation phase. Our Advance Duo bundle pairs 1mg with 1.7mg for £269.99, providing seamless progression through weeks 9-16 of your treatment. The Consistency 1mg bundle offers two pens for £209.99, ideal if your prescriber recommends staying at this dose longer before escalation. These bundle options provide convenience and Reliable Supply continuity without the need for multiple orders.
When comparing what 1mg Wegovy costs versus Mounjaro's equivalent phase, consider that both treatments follow different dose escalation schedules and mechanisms of action. Mounjaro's tirzepatide targets both GIP and GLP-1 receptors, while Wegovy's semaglutide focuses solely on GLP-1 receptor activation. Both are available from our GPhC-registered pharmacy (#9012878) with the same professional clinical assessment process, next-day cold-chain delivery, and ongoing prescriber support throughout your weight management journey.
Clinical Evidence: What 1mg Wegovy in Mounjaro Comparison Studies Show
In clinical trials, patients taking Wegovy alongside diet and exercise achieved significant weight management results, with the STEP 1 trial (Wilding et al., NEJM, 2021) demonstrating approximately 15% average weight loss at 68 weeks versus 2.4% with placebo. The 1mg dose represents an important escalation phase where patients typically begin experiencing more pronounced appetite regulation effects. Clinical studies show that proper dose escalation, including the 1mg phase, may help minimize gastrointestinal side effects while building therapeutic efficacy.
When considering what 1mg Wegovy represents compared to Mounjaro's clinical profile, both treatments have demonstrated efficacy in their respective trial programmes, though direct head-to-head comparisons use different trial designs and patient populations. Mounjaro's dual-hormone approach showed promising results in its SURMOUNT trials, while Wegovy's GLP-1-focused mechanism has extensive real-world evidence. Your prescriber can help determine which treatment approach and monthly cost structure align best with your individual circumstances and weight management goals.
How Wegovy 1mg Works: GLP-1 Mechanism During Month 3 of Treatment
Wegovy 1mg contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone, becoming particularly effective during weeks 9-12 of treatment. At this stage, many patients report established appetite regulation, reduced food cravings, and improved feelings of satiety after smaller meals. The medication works on your brain's appetite centres, potentially helping you feel satisfied with appropriate portion sizes throughout your monthly treatment cycle. Unlike Mounjaro's dual GIP and GLP-1 approach, Wegovy focuses exclusively on GLP-1 receptor activation, providing targeted appetite regulation support. By month three of treatment, the 1mg dose may help establish sustainable eating patterns that support your long-term weight management goals alongside lifestyle modifications.
Ordering Process: Getting Your Monthly Wegovy 1mg Supply
Starting your Wegovy 1mg monthly supply requires completing our 3-minute online clinical assessment, covering your medical history, current medications, and weight management goals. Our prescribers review your assessment within 3 working days (express 24-hour service available), ensuring Wegovy 1mg is clinically appropriate for your stage of treatment. Once approved, your prescription-only medicine ships via next-day delivery using specialized cold-chain packaging to maintain the required 2-8°C temperature throughout transit. Our GPhC-registered pharmacy (#9012878) handles all aspects of your prescription processing, from clinical review to doorstep delivery. The streamlined process ensures consistent monthly supply continuity, with automated reminders available to help you reorder before running out of your current pen.
Storage and Practical Considerations: Managing Your Monthly Wegovy 1mg
Your Wegovy 1mg pen must be stored in the fridge at 2-8°C before first use, but offers superior travel flexibility with up to 6 weeks at room temperature below 30°C once removed from refrigeration. This storage advantage over Mounjaro's 21-day room temperature limit makes Wegovy particularly convenient for busy lifestyles, holidays, or business travel during your monthly treatment cycle. The FlexTouch pen design ensures accurate dosing with a simple once-weekly injection, typically administered on the same day each week. Each pen contains four weekly doses, perfectly aligning with your monthly prescription cycle from weeks 9-12 of your dose escalation journey. Proper storage and injection technique maximize the medication's effectiveness while maintaining the sterile integrity required for this prescription-only medicine.
Budgeting Your Weight Management Journey: What 1mg Wegovy Monthly Costs Mean Long-term
Understanding what 1mg Wegovy costs as part of your complete treatment timeline helps you budget effectively for long-term weight management success. Your monthly costs progress from £79.99 (0.25mg starter), £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for maintenance 2.4mg dosing. This transparent escalation schedule means your annual maintenance cost settles at approximately £2,519.88 once you reach the 2.4mg maintenance phase. Many patients find the structured monthly approach easier to budget than unpredictable healthcare costs, with the knowledge that maintenance dosing provides consistent monthly expenses.
When comparing what 1mg Wegovy represents financially versus Mounjaro's cost structure, both treatments require long-term commitment for sustained results, as clinical evidence suggests weight regain occurs if treatment discontinuation happens. Planning your monthly prescription budget becomes part of your overall investment in health, similar to gym memberships or nutrition programmes, but with the advantage of clinical oversight and proven efficacy data. The DOSE25 discount code ensures returning customers maintain competitive pricing throughout their weight management journey.
Making Your Choice: Wegovy 1mg vs Mounjaro Monthly Investment
Both Wegovy and Mounjaro are available from EverydayMeds, allowing your prescriber to help determine which treatment and monthly cost structure suits your individual needs best. Your choice between Wegovy's GLP-1-focused approach at £99.99 monthly (1mg phase) versus Mounjaro's dual-hormone mechanism depends on clinical factors, lifestyle preferences, and budget considerations. Our clinical team provides ongoing support throughout your treatment journey, helping you navigate dose adjustments, side effect management, and long-term success strategies. Start your clinical assessment today using code FIRST40 to secure your preferred treatment option, with the confidence of professional oversight from our GPhC-registered pharmacy. Visit https://everydaymeds.co.uk/products/wegovy-1mg to begin your weight management journey with transparent monthly pricing and expert clinical support.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
